Pablo Ortiz Cerezo, MD
Urology · San Juan, PRNPI 1770550048
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Verity Pharmaceuticals Inc. accounts for 88.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $11,019 and has fallen 97.7% since, to $254 in 2025.
Across 31 payments — averaging $637.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Verity Pharmaceuticals Inc.$17K
- Boston Scientific$1K
- Travere Therapeutics, Inc.$366
- Merck$224
- Teleflex LLC$134
- BD$130
- plus $466 from 4 others
What the payments were for
- Consulting fees$11,00056%
- Speaking & faculty fees$6,00030%
- Food & beverage$2,75614%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Verity Pharmaceuticals Inc. | 9 | $17,414 |
| Boston Scientific | 9 | $1,022 |
| Travere Therapeutics, Inc. | 4 | $366 |
| Merck | 2 | $224 |
| Teleflex LLC | 2 | $134 |
| BD | 1 | $130 |
| Ferring Pharmaceuticals Inc. | 1 | $128 |
| Progenics Pharmaceuticals, Inc. | 1 | $124 |
| Urogen Pharma, Inc. | 1 | $114 |
| Pfizer Pharmaceuticals LLC | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELSTAR$17,125
- GENERAL BPH$256
- (815) Thiola$249
- KEYTRUDA$224
- REZUM$206
- Proxis Ureteral Access Sheath$130
- GENERAL KIDNEY STONE DISEASE$130
- UroLift$128
- ADSTILADRIN$128
- TLANDO$125
- GENERAL - THERAPIES$125
- PYLARIFY$124
- Vibativ$120
- JELMYTO$114
- XTANDI$100
How this compares
$19,756 in reported general payments places this provider in the 85th percentile of 122 urology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tolterodine Tartrate ErTolterodine Tartrate | 183 | $11,444 |
| Tamsulosin Hcl | 347 | $3,060 |
| Tadalafil | 23 | $2,201 |
| Estradiol | 19 | $1,746 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 72 | $852 |
| Ciprofloxacin Hcl | 101 | $715 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 116 | $473 |
| Terconazole | 11 | $355 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $304 |
| Paroxetine Hcl | 17 | $198 |
| Sildenafil Citrate | 20 | $149 |
| Finasteride | 18 | $144 |
| Ibuprofen | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other urology in San Juan
- Andres Perez RomanSan Juan$58K
- Rafael Bouet BlasiniSan Juan$55K
- Jose Saavedra-BelaundeSan Juan$45K
- Francisco CapoSan Juan$38K
- Gil NievesSan Juan$30K
- Francois Soto PalouSan Juan$26K
- Jorge Rivera HerreraSan Juan$19K
- Eduardo CantoSan Juan$17K
- Hector Cardona DobleSan Juan$13K
- Antonio Puras BaezSan Juan$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.